CARLSBAD, Calif., Sept. 7, 2011 /PRNewswire/ -- SkinMedica, the fastest growing professional skin care company in the United States, has revolutionized the anti-aging category with the introduction of Biometa Essential Serum - the first product from SkinMedica to be launched exclusively in select international markets.
(Logo: http://photos.prnewswire.com/prnh/20110802/NY45723LOGO )
Biometa Essential Serum is an all inclusive skin care treatment that significantly addresses the visible signs of aging. This new product is the result of years of innovative scientific research that targets the natural aging pathways of the skin. Biometa Essential Serum unlocks the rejuvenation process, resulting in long lasting natural beauty.
"Our understanding of the biological pathways associated with the body's natural regenerative qualities is constantly advancing," said Rahul Mehta PhD, Executive Director of R&D. "We are dedicated to providing products with clinically demonstrated patient benefits based on the latest scientific understanding."
In clinical studies, Biometa Essential Serum showed results in all visible signs of aging that appeared short-term and continued over time. Patients in the studies reported significant improvement in the following:
- 88%: improved the appearance of wrinkles
- 97%: product is convenient to use
- 97%: improved skin smoothness
- 91%: product led to tighter, firmer skin
- 91%: improved skin softness
- 91%: improved skin texture
Biometa Essential Serum recently launched in Asia, The European Union and will launch in key regions in Latin America and Middle East soon. Visit www.biometaessentialserum.com for more information.
SkinMedica, Inc. is focused on developing, acquiring and commercializing products that improve the appearance of skin. The Company markets and sells to physicians, with a focus on aesthetics, both prescription and non-prescription skin care products. The Company's full line of aesthetic skin care products includes the revolutionary TNS Essential Serum and hallmark TNS Recovery Complex®. The formulations in the Company's clinical skin care collection enhance skin appearance, reduce signs of aging and provide other skin care benefits.
SkinMedica's primary prescription product is VANIQA® (eflornithine hydrochloride) Cream, 13.9%, the only FDA-approved prescription product for the reduction of unwanted facial hair in women.
SkinMedica is based in Carlsbad, California. For more information, visit: www.skinmedica.com.
TNS Recovery Complex®, VANIQA®, and SkinMedica®, are registered trademarks of SkinMedica, Inc and affiliates.
SOURCE SkinMedica, Inc.